ICAN aims to build country capacity in the generation and use of cost evidence for sustainable and predictable financing for immunization. ICAN’s four member countries – India, Indonésien, Tanzanie, and Vietnam – generated evidence to address the challenges at the top of their health and immunization financing agendas. The research summary for each country includes a summary presentation, executive summary, study report, and an evidence to policy and practice plan.
Indonésien: What are the costs of delivering vaccines using different delivery strategies in high coverage areas in Indonesia?
Tanzanie: What does it cost to immunize children up to 18 months of age using the current mix of delivery strategies in rural and urban areas in Tanzania?
Vietnam: What are the costs associated with introducing Tetanus-Diphtheria vaccine and ceasing delivery of Tetanus-Typhoid vaccine in Vietnam?
Inde: What are the delivery costs and the cost drivers of the Measles-Rubella vaccination campaign in India?